Unique spatial immune profiling in pancreatic ductal adenocarcinoma with enrichment of exhausted and senescent T cells and diffused CD47-SIRP? expression
Chiloeches, M. L.
Chouliari, N. V.
Samaras, M. G.
Veltsista, P. D.
Theodorou, S. D. P.
Margetis, A. T.
Lazaris, A. C.
Gorgoulis, Vassilis G
Pateras, I. S.
AffiliationFirst Department of Surgery, Laikon University Hospital, National and Kapodistrian University of Athens, 11527 Athens, Greece
MetadataShow full item record
AbstractBackground: Pancreatic ductal adenocarcinoma (PDAC) is resistant to single-agent immunotherapies. To understand the mechanisms leading to the poor response to this treatment, a better understanding of the PDAC immune landscape is required. The present work aims to study the immune profile in PDAC in relationship to spatial heterogeneity of the tissue microenvironment (TME) in intact tissues. Methods: Serial section and multiplex in situ analysis were performed in 42 PDAC samples to assess gene and protein expression at single-cell resolution in the: (a) tumor center (TC), (b) invasive front (IF), (c) normal parenchyma adjacent to the tumor, and (d) tumor positive and negative draining lymph nodes (LNs). Results: We observed: (a) enrichment of T cell subpopulations with exhausted and senescent phenotype in the TC, IF and tumor positive LNs; (b) a dominant type 2 immune response in the TME, which is more pronounced in the TC; (c) an emerging role of CD47-SIRP? axis; and (d) a similar immune cell topography independently of the neoadjuvant chemotherapy. Conclusion: This study reveals the existence of dysfunctional T lymphocytes with specific spatial distribution, thus opening a new dimension both conceptually and mechanistically in tumor-stroma interaction in PDAC with potential impact on the efficacy of immune-regulatory therapeutic modalities. Keywords: CD47; T cell exhaustion; T cell senescence; draining lymph nodes; macrophage checkpoint; neoadjuvant chemotherapy; pancreatic ductal adenocarcinoma; signal regulatory protein alpha (SIRP?); spatial heterogeneity; tumor microenvironment.
CitationPapalampros A, Vailas M, Ntostoglou K, Chiloeches ML, Sakellariou S, Chouliari NV, et al. Unique Spatial Immune Profiling in Pancreatic Ductal Adenocarcinoma with Enrichment of Exhausted and Senescent T Cells and Diffused CD47-SIRPalpha Expression. Cancers (Basel). 2020;12(7).
- Single-cell RNA sequencing reveals compartmental remodeling of tumor-infiltrating immune cells induced by anti-CD47 targeting in pancreatic cancer.
- Authors: Pan Y, Lu F, Fei Q, Yu X, Xiong P, Yu X, Dang Y, Hou Z, Lin W, Lin X, Zhang Z, Pan M, Huang H
- Issue date: 2019 Nov 27
- The reciprocal regulation between host tissue and immune cells in pancreatic ductal adenocarcinoma: new insights and therapeutic implications.
- Authors: Liu X, Xu J, Zhang B, Liu J, Liang C, Meng Q, Hua J, Yu X, Shi S
- Issue date: 2019 Dec 13
- Immune Checkpoint Inhibition for Pancreatic Ductal Adenocarcinoma: Current Limitations and Future Options.
- Authors: Kabacaoglu D, Ciecielski KJ, Ruess DA, Algül H
- Issue date: 2018
- Current advances and outlooks in immunotherapy for pancreatic ductal adenocarcinoma.
- Authors: Fan JQ, Wang MF, Chen HL, Shang D, Das JK, Song J
- Issue date: 2020 Feb 15